期刊
PLOS COMPUTATIONAL BIOLOGY
卷 15, 期 2, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pcbi.1006791
关键词
-
资金
- EMBL
- RCSB PDB
- NCI/NIH [U01 CA198942]
- AbbVie
- Bayer Pharma AG
- Boehringer Ingelheim
- Canada Foundation for Innovation
- Eshelman Institute for Innovation
- Genome Canada through Ontario Genomics Institute [OGI-055]
- Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant] [115766]
- Janssen
- Merck KGaA (Darmstadt, Germany)
- MSD
- Novartis Pharma AG
- Ontario Ministry of Research
- Innovation and Science (MRIS)
- Pfizer
- So Paulo Research Foundation-FAPESP
- Takeda
- Wellcome [106169/Z/14/Z]
- COST Action [BM1405]
- COST Switzerland SEFRI project [IZCNZ0-174836]
- National Science Foundation [NSF-DBI 1338415]
- National Institute of General Medical Sciences [NSF-DBI 1338415]
- National Cancer Institute [NSF-DBI 1338415]
- Department of Energy [NSF-DBI 1338415]
- ZHAW
- SGC
- Wellcome Trust [106169/Z/14/Z] Funding Source: Wellcome Trust
BioJava is an open-source project that provides a Java library for processing biological data. The project aims to simplify bioinformatic analyses by implementing parsers, data structures, and algorithms for common tasks in genomics, structural biology, ontologies, phylogenetics, and more. Since 2012, we have released two major versions of the library (4 and 5) that include many new features to tackle challenges with increasingly complex macromolecular structure data. BioJava requires Java 8 or higher and is freely available under the LGPL 2.1 license. The project is hosted on GitHub at https://github.com/biojava/biojava. More information and documentation can be found online on the BioJava website (http://www.biojava.org) and tutorial (https://github.com/biojava/biojava-tutorial). All inquiries should be directed to the GitHub page or the BioJava mailing list (http://lists.open-bio.org/mailman/listinfo/biojava-l).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据